Inflammatory biomarkers in blood of patients with acute brain ischemia (Q44894573)

7 December 2017

Inflammatory biomarkers in blood of patients with acute brain ischemia (English)

1 reference

7 December 2017

0 references

0 references

0 references

6

1 reference

7 December 2017

S Sotgiu

1

1 reference

7 December 2017

B Zanda

2

1 reference

7 December 2017

B Marchetti

3

1 reference

7 December 2017

M L Fois

4

1 reference

7 December 2017

G Arru

5

1 reference

7 December 2017

F S Salaris

7

1 reference

7 December 2017

A Arru

8

1 reference

7 December 2017

A Pirisi

9

1 reference

7 December 2017

G Rosati

10

1 reference

7 December 2017

language of work or name

1 reference

1 May 2006

1 reference

European Journal of Neurology

7 December 2017

1 reference

7 December 2017

13

1 reference

7 December 2017

5

1 reference

7 December 2017

505-513

1 reference

Cytokine imbalance in non-immunological chronic disease.

7 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

Inflammatory cell adhesion molecules in ischemic cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

Biochemical changes and inflammatory response as markers for brain ischaemia: molecular markers of diagnostic utility and prognosis in human clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

Leukocyte count predicts outcome after ischemic stroke: the Northern Manhattan Stroke Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

What are surrogate outcome measures and why do they fail in clinical research?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

The efficient calculation of neurosurgically relevant volumes from computed tomographic scans using Cavalieri's Direct Estimator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

Control of glial immune function by neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

The inflammatory response in cerebral ischemia: focus on cytokines in stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

Unfractionated heparin is associated with a lower rise of serum vascular cell adhesion molecule-1 in acute ischemic stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

Interleukin-6 expression and regulation in astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

Proinflammatory cytokines, measured in a mixed population on arrival in the emergency department, are related to mortality and severity of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

Plasmatic level of neuroinflammatory markers predict the extent of diffusion-weighted image lesions in hyperacute stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

Effects of simvastatin and atorvastatin on inflammation markers in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

Statin-induced immunomodulatory effects on human T cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

Inflammation and infections as risk factors for ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

Multiple sclerosis complexity in selected populations: the challenge of Sardinia, insular Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

Investigation of a genetic variation of a variable number tandem repeat polymorphism of interleukin-6 gene in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

Immunological heterogeneity of multiple sclerosis in Sardinia and Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

Searching for the exercise factor: is IL-6 a candidate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

Interleukin-6 is a positive regulator of tumor necrosis factor alpha-induced adipose-related protein in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

Insulin stimulates interleukin-6 and tumor necrosis factor-alpha gene expression in human subcutaneous adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

Effects of transient loss of shear stress on blood-brain barrier endothelium: role of nitric oxide and IL-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

Inflammation in multiple sclerosis: the good, the bad, and the complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

Cytokines in neurodegeneration and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

Neuroprotection in transient focal brain ischemia after delayed intravenous administration of brain-derived neurotrophic factor conjugated to a blood-brain barrier drug targeting system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

Effect of brain-derived neurotrophic factor treatment and forced arm use on functional motor recovery after small cortical ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

Proinflammatory cytokines and early neurological worsening in ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

Association between longevity and cytokine gene polymorphisms. A study in Sardinian centenarians

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01280.X

10.1111/J.1468-1331.2006.01280.X

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference